Clinical Trials Sponsored by Metagenics Europe

Total 2721 results

F2G Biotech GmbH
Bio-Kinetic Europe, Ltd.

Withdrawn

Drug/Drug Interactions With F901318

Invasive Aspergillosis
Astellas Pharma Europe B.V.

Completed

A Phase 1 Study to Investigate the Mechanism of Action of Ipragliflozin

Type 2 Diabetes Mellitus

Germany
Astellas Pharma Europe B.V.

Completed

Study of Solifenacin Succinate and Tamsulosin Hydrochloride OCAS in Males With Lower Urinary Tract Symptoms (Neptune)

Lower Urinary Tract Symptoms | Benign Prostatic Hyperplasia

Belgium, Italy, France, Austria, United Kingdom, Netherlands, Hungary, Russian Federation, Poland, Slovakia, Czech Republic, Belarus, Germany
Astellas Pharma Europe B.V.

Completed

Study to Test the Efficacy and Safety of YM178 in Subjects With Symptoms of Overactive Bladder (Blossom)

Urinary Bladder, Overactive

Belgium, Czech Republic, Germany, Spain, Sweden, United Kingdom
Astellas Pharma Europe B.V.

Completed

An Observational Study Looking at How Well the Drug Eligard Works and How Well it is Tolerated by the Body of Patients With Advanced Prostate Carcinoma in the Russian Federation

Advanced Prostate Carcinoma

Russian Federation
Astellas Pharma Europe Ltd.

Completed

Study to Evaluate the Safety and Pharmacokinetics of Single Doses of ASP2151 in Healthy Male Subjects and the Effects of Food

Herpes Zoster | Herpes Genitalis

France
Astellas Pharma Europe B.V.

Completed

A Combined Single and Multiple Ascending Dose Study of ASP6858 in Healthy Subjects

Healthy Volunteers

United Kingdom
Astellas Pharma Europe B.V.

Completed

A Study Evaluating Efficacy and Safety of YM150 Compared to Enoxaparin in Subjects Undergoing Hip Replacement Surgery (ONYX-3)

Venous Thromboembolism | Arthroplasty, Replacement, Hip

Denmark, Spain, United States, Austria, Colombia, Russian Federation, India, Italy, United Kingdom, Germany, Hungary, Estonia, Romania, South Africa, Israel, Poland, Sweden, Canada, Australia, Lithuania, Ukraine, Latvia, Finland, Brazil, Slovak... and more
Astellas Pharma Europe B.V.

Completed

A Study to Investigate the Effect of Oral Doses of Pilocarpine on Salivary Secretion and Static Pupillometry in Healthy Subjects

Healthy Subjects

United Kingdom
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Safety, Tolerability and Effects of Single and Multiple Ascending Doses of ASP1707 in Healthy Male and Pre-menopausal Female Subjects, Including a Comparison of the Effects Under Fasted and Fed Conditions in Healthy Young Male Subjects

Pharmacokinetics of ASP1707 | Pharmacodynamics of ASP1707

France
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

A Study of Solifenacin With Bladder Training Versus Solifenacin Alone in Patients With Overactive Bladder (SOLAR) (SOLAR)

Overactive Bladder | Urinary Incontinence | Urge Incontinence

France, Belgium, Spain, Turkey, Australia, Russian Federation, Hungary, Italy, Netherlands, Poland, Czech Republic
Astellas Pharma Europe B.V.

Completed

A Study to Evaluate Whether Verapamil Has an Effect on the Uptake and Elimination of Solifenacin and Tamsulosin When Administered in a Combination Tablet

Healthy Subjects | Drug-Drug Interaction (DDI)

France
Astellas Pharma Europe B.V.

Completed

A Study to Compare the Amount of Drug in the Blood After a Single Tablet EC905 Containing Solifenacin and Tamsulosin is Taken by Healthy Males Compared to Separate Tablets of Solifenacin and Tamsulosin

Healthy Subjects | Pharmacokinetics | EC905

United Kingdom
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Pharmacokinetics, Metabolism and Excretion Routes of ASP3652 in Man, After Administration of 14C Radio Labeled ASP3652

Healthy Subjects | Pharmacokinetics of ASP3652

United Kingdom
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

A Study of YM178 in Patients With Symptomatic Overactive Bladder (DRAGON)

Overactive Bladder

Poland, United Kingdom, Germany, Spain, Netherlands, Belgium, Czech Republic, Italy, Norway, Hungary, Sweden, Denmark, Greece, France, Russian Federation
Astellas Pharma Europe B.V.

Completed

A Study to Compare the Actions in the Body of Healthy Subjects of Three Modified Release Formulations of YM178 Under Fasted and Fed Conditions With One Immediate Release Formulation of YM178 Under Fasted Conditions

Healthy Subjects | Pharmacokinetics of YM178

Netherlands
Astellas Pharma Europe B.V.

Completed

A Study to Find Out How YM150 is Absorbed Into and Eliminated From the Body in Healthy Male Subjects

Healthy Male Subjects | Pharmacokinetics

Netherlands
Astellas Pharma Inc
Astellas Pharma Europe B.V.

Completed

Factor Xa Inhibitor YM150 for the Prevention of Blood Clot Formation in Veins After Scheduled Hip Replacement (ONYX-2)

Thromboembolism

Italy, Spain, Sweden, Austria, Denmark, Russian Federation, Poland, Bosnia and Herzegovina, Serbia, Norway, Latvia, Finland, Lithuania, Czech Republic, Germany, Slovakia, Greece
Astellas Pharma Europe B.V.

Completed

A Study to Assess the Safety, Tolerability and Effects of Single Ascending Doses of ASP3652 in Healthy Subjects

Healthy Subjects | Pharmacokinetics | Pharmacodynamics | Safety

Netherlands
AlgiPharma AS
Imperial College London; Cystic Fibrosis Foundation; University Hospital of Cologne and other collaborators

Withdrawn

A Dose-finding Study of Inhaled OligoG vs Placebo in Patients With Cystic Fibrosis (SMR3372)

Cystic Fibrosis

Germany
Euromi Biosciences

Recruiting

Prospective Observational Clinical Follow-up of Euromi Biosciences Pre-filled Silicone Gel Breast Implants (ELEGANT)

Breast Implant Rupture | Breast Implant; Complications

France
European Hospital

Completed

Natural Cycle Versus Endometrial Preparation for Healthy Blastocyst Transfer

Infertility

Italy
European Hospital

Unknown

Influence of Culture Media on Clinical Outcomes in Poor Responders or Severe Male Infertility

Embryo Development | Blastocyst | Culture Media | Poor Responder | Severe Male Infertility

Italy
European Hospital

Completed

Randomized Comparison of xiEnce and visioN Coronary Stents in the sAme muLtivessel Patient With Chronic kiDnEy diSease (RENAL-DES)

Chronic Kidney Disease | Multivessel Coronary Artery Disease

Italy
European Hospital

Unknown

The Results of Preimplantation Genetic Diagnosis and Preimplantation Genetic Screening of Embryos Obtained From GnRH-agonist Long and GnRH-antagonist Ovarian Stimulation Protocol

Embryo's Genetic and Chromosomal Quality

Italy
European LeukemiaNet

Completed

European Stop Tyrosine Kinase Inhibitor Study (EURO-SKI)

Chronic Myeloid Leukemia

France, Denmark, Norway, Sweden, Czechia, Portugal, Germany, Netherlands, Finland, Greece
Neurop Inc.

Completed

Safety and Pharmacokinetics of NP10679 in Normal Healthy Volunteers

Safety Issues

United States
Kurobe LLC

Completed

Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis

Bacterial Conjunctivitis

United States
Clinique de lEurope a Amiens

Recruiting

Early Post-operative Monitoring by Sensor of Patients Undergoing Forefoot Surgery

Foot Injury

France
Universidad Europea de Madrid
3M

Terminated

Clinical Evaluation of the Performance of a Newly Developed Glass Ionomer Restorative for Posterior Restorations in an Adult Population

Tooth Wear | Glass Ionomer Cements

Spain
Universidad Europea de Madrid
apoyopositivo.org

Completed

Effects of an ACT-based Psychological Treatment in Patients With Hypersexuality

Hypersexuality | Compulsive Sexual Behavior

Spain
Semmelweis University
NSK Europe GmbH; Hungarian Dental Association

Recruiting

Modified Ridge Splitting Technique Using Autogenous Bone Blocks (MRS) (MRS)

Alveolar Bone Resorption | Alveolar Ridge Enlargement

Hungary
Parc de Salut Mar
Fundacion IMIM; EMDR Europe

Completed

Efficacy of EMDR Therapy, as Compared to Treatment as Usual, in Reducing Clinical Symptoms in People With HIV

PTSD | HIV/AIDS | Psychological Trauma

Spain
Parc de Salut Mar
Fundacion IMIM; EMDR Europe

Completed

EMDR in Psychiatric Inpatients With Severe Mental Disorder

Psychological Trauma | Severe Mental Disorder

Spain
Emanuela Keller
CytoSorbents Europe GmbH

Terminated

CytoSorb SAH Trial

Aneurysmal Subarachnoid Haemorrhage

Switzerland
Astellas Pharma Europe B.V.
FibroGen

Completed

Roxadustat in the Treatment of Anemia in Chronic Kidney Disease (CKD) Patients, Not on Dialysis, in Comparison to Darbepoetin Alfa (Dolomites)

Anemia in Chronic Kidney Disease in Non-dialysis Patients

Austria, Belarus, Bulgaria, Croatia, Czechia, Finland, France, Georgia, Germany, Hungary, Ireland, Israel, Latvia, Montenegro, Netherlands, North Macedonia, Poland, Portugal, Romania, Russian Federation, Serbia, Slovakia, Slovenia, Spain and more
University of Witten/Herdecke
KCI Europe Holding B.V.

Completed

Treatment Study of Vacuum Assisted Closure for Postsurgical Subcutaneous Abdominal Wound Healing Impairments (SAWHI)

Impaired Wound Healing | Wound Healing Disorder | Abdominal Wound Healing Disorder | Abdominal Wound Healing Impairment | Acute Postsurgical Subcutaneous Wound

Belgium, Germany
ECRI bv
Terumo Europe N.V.; Abbott Medical Devices

Completed

ABSORB STEMI: the TROFI II Study

Acute ST Segment Elevation Myocardial Infarction

Denmark, Netherlands, Spain, Switzerland
Medical University of Lublin
Aeon Astron Europe B.V.

Completed

Phacotrabeculectomy With Collagen Matrix Implant (Ologen®) Versus Mitomycin C

Glaucoma | Cataract | Wound Heal
Maastricht University Medical Center
Aeon Astron Europe B.V.

Terminated

Trabeculectomy With Ologen

Glaucoma

Netherlands
Astellas Pharma Europe B.V.
FibroGen

Completed

A Study to Evaluate the Dose-proportionality and Effects of FG-4592 in Healthy Young and Elderly Male and Female Subjects

Healthy Subjects | PK for FG-4592

Germany
Astellas Pharma Europe B.V.
FibroGen

Completed

A Study to Investigate the Exposure and Safety and Tolerability of a Single Dose of FG-4592 in Subjects With Moderately Diminished Liver Function Compared to Those With Normal Liver Function

Hepatic Insufficiency | Healthy Subjects | PK of FG-4592

Bulgaria
Maastricht University Medical Center
Bioriginal Europe / Asia B.V.

Completed

Stearidonic Acid and Lipid Metabolism

Lipid Metabolism Disorders

Netherlands
Southern Europe New Drug Organization
Novartis; Schering-Plough

Unknown

Dose-finding Study of CAELYXTM and RAD001 in Patients With Advanced Solid Tumors

Advanced Solid Tumors

Italy, Switzerland
University of Cologne
Ethicon Endo-Surgery (Europe) GmbH

Unknown

Monopolar Electrosurgery Versus Ultrasound Scissors in Thoracoscopic Ventral Spondylodesis (Harmonic)

Fractures of Vertebral Bodies

Germany
EUROS

Recruiting

Post Market Clinical Follow-up of Dual-mobility Acetabular Cup EUROSCUP MOBILE

Hip Fractures | Hip Dysplasia | Hip Osteoarthritis | Hip Arthritis | Hip Arthropathy | Hip Necrosis

France
EUROS

Active, not recruiting

Post Market Clinical Follow-up of EUROSTEM Femoral Stem

Hip Fractures | Hip Dysplasia | Hip Osteoarthritis | Hip Arthritis | Hip Arthropathy | Hip Necrosis

France
Novadip Biosciences
PrimeVigilance; Data Investigation Company Europe (DICE)

Recruiting

Study With NVDX3 for Treatment of Low Grade Degenerative Lumbar Spondylolisthesis

Degenerative Lumbar Spondylolisthesis

Luxembourg
NEC Corporation
Meditrial Europe Ltd.; Meditrial USA Inc.

Recruiting

Real-time Computer-Aided Detection of Colonic Adenomas With NEC WISE VISION® Endoscopy (COLOWISE)

Colorectal Cancer | Polyp of Colon | Adenoma Colon

United States, Italy, Germany, United Kingdom
Biosensors Europe SA
Biosensors Interventional Technologies Pte Ltd

Completed

Asian Registry of the BioFreedom Stent for STEMI Patients

STEMI - ST Elevation Myocardial Infarction

Taiwan, Hong Kong, Singapore, Korea, Republic of, Thailand

Clinical Trials Sponsored by Metagenics Europe

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Israel

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations